Pulmonary and lymph node lesions and leukopenia which developed in dogs after plutonium-239 and -238 dioxide inhalation have been related to various radiation dose parameters, over a wide range of postexposure time intervals (16-468 days). The degree of radiation pathology in lungs was found to increase with increasing accumulated alpha doses above 1500-2000 rads and up to about 15,000 rads. In general no damage to tracheobronchial lymph nodes was evident unless radiation changes were also present in the lungs. The degree and extent of the lymph node changes did not correlate well with estimates of total lymph node dose, but there was a relatively good relationship with dose rate (rads per day) to the lymph nodes adjacent to trachea and main bronchi. Radiation changes in both types of tissue, and due to both plutonium isotopes, were unrelated to length of postexposure period except for increasing fibrosis with time. In contrast, the leukopenia which developed was related to mean, post-exposure, fixed tissue burdens but not to rad dose except in experiments of similar duration. The findings indicate that the lung lesions reflect total accumulated pulmonary doses while lymph nodes are more sensitive to dose rate. It is suggested that the leukopenia developed as a result of irradiation of circulating cells by localized deposits of plutonium in lymph nodes and probably lungs, rather than to depression of hematopoiesis and/or lymphopoiesis.
Skip Nav Destination
Research Article| December 01 1970
Dose-Related Local and Systemic Effects of Inhaled Plutonium-238 and Plutonium-239 Dioxide in Dogs
Radiat Res (1970) 44 (3): 821–834.
- Views Icon Views
- Share Icon Share
- Search Site
C. L. Yuile, F. R. Gibb, P. E. Morrow; Dose-Related Local and Systemic Effects of Inhaled Plutonium-238 and Plutonium-239 Dioxide in Dogs. Radiat Res 1 December 1970; 44 (3): 821–834. doi: https://doi.org/10.2307/3573159
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr